Omeros (OMER) EBT Margin Growth (1y) (2011 - 2022)

Omeros (OMER) EBT Margin Growth (1y) (2011 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,526.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,558.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -683.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 452.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Omeros 739.31 Mn 739.31 Mn 9.31 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2022 -13,747.00
Mar 31, 2022 -33,568.00
Dec 31, 2021 95,694.00
Sep 30, 2021 10,170.00
Jun 30, 2021 23,261.00
Mar 31, 2021 -11,783.00
Dec 31, 2020 -49,051.00
Sep 30, 2020 -12,222.00
Jun 30, 2020 -27,892.00
Mar 31, 2020 -1,162.00
Dec 31, 2019 -26,923.00
Sep 30, 2019 363,249.00
Jun 30, 2019 635,049.00
Mar 31, 2019 180,749.00
Dec 31, 2018 11,262.00
Sep 30, 2018 -314,584.00
Jun 30, 2018 -576,277.00
Mar 31, 2018 -134,277.00
Dec 31, 2017 -6,731.00
Sep 30, 2017 -19,846.00